Terms: = Liver cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
125 results:
1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
2. Hepatic Stellate Cell-Targeting Micelle Nanomedicine for Early Diagnosis and treatment of liver Fibrosis.
Wang L; Zhou J; Wang J; Wang X; Dong H; Zhao L; Wu J; Peng J
Adv Healthc Mater; 2024 May; 13(12):e2303710. PubMed ID: 38293743
[TBL] [Abstract] [Full Text] [Related]
3. C-X-C motif chemokine receptor 4 inhibition promotes the effect of plantamajoside in hepatocellular carcinoma.
Sun J; Liu W; Fu H; Li Y; Huang J; Wang Y; Zhu L
Arab J Gastroenterol; 2024 Feb; 25(1):28-36. PubMed ID: 38220479
[TBL] [Abstract] [Full Text] [Related]
4. Weekend Effect on Clinical Outcomes of Acute Lower Gastrointestinal Bleeding: A Large Multicenter Cohort Study in Japan.
Hayasaka J; Kikuchi D; Ishii N; Kobayashi K; Yamauchi A; Yamada A; Omori J; Ikeya T; Aoyama T; Tominaga N; Sato Y; Kishino T; Sawada T; Murata M; Takao A; Mizukami K; Kinjo K; Fujimori S; Uotani T; Fujita M; Sato H; Suzuki S; Narasaka T; Funabiki T; Kinjo Y; Mizuki A; Kiyotoki S; Mikami T; Gushima R; Fujii H; Fuyuno Y; Gunji N; Toya Y; Narimatsu K; Manabe N; Nagaike K; Kinjo T; Sumida Y; Funakoshi S; Kobayashi K; Matsuhashi T; Komaki Y; Miki K; Watanabe K; Odagiri H; Hoteya S; Kaise M; Nagata N
Dig Dis; 2023; 41(6):890-899. PubMed ID: 37669627
[TBL] [Abstract] [Full Text] [Related]
5. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract] [Full Text] [Related]
6. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
Lu G; Wang X; Cheng M; Wang S; Ma K
Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
[TBL] [Abstract] [Full Text] [Related]
7. Potential role of human umbilical cord stem cells-derived exosomes as novel molecular inhibitors of hepatocellular carcinoma growth.
ElBadre HM; El-Deek SEM; Ramadan HK; Elbadr MM; Sabry D; Ahmed NM; Ahmed AM; El-Mahdy RI
Apoptosis; 2023 Oct; 28(9-10):1346-1356. PubMed ID: 37338718
[TBL] [Abstract] [Full Text] [Related]
8. cxcr4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/cxcr4 signaling axis in preclinical breast cancer model.
Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G
Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620
[TBL] [Abstract] [Full Text] [Related]
9. 68Ga-Pentixafor PET/MRI for treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion cxcr4 Expression on PET and Lesion Size and Diffusivity on MRI.
Mayerhoefer ME; Raderer M; Weber M; Lamm W; Kiesewetter B; Hacker M; Nics L; Schmitl S; Leithner D; Wester HJ; Haug A
Clin Nucl Med; 2023 Jul; 48(7):557-562. PubMed ID: 37272977
[TBL] [Abstract] [Full Text] [Related]
10. In vivo validation of
Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ
Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392
[TBL] [Abstract] [Full Text] [Related]
11. Loganic acid regulates the transition between epithelial and mesenchymal-like phenotypes by alleviating MnSOD expression in hepatocellular carcinoma cells.
Kim NY; Ha IJ; Um JY; Kumar AP; Sethi G; Ahn KS
Life Sci; 2023 Mar; 317():121458. PubMed ID: 36731649
[TBL] [Abstract] [Full Text] [Related]
12. Sequential treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal cancer liver Metastasis.
Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
[TBL] [Abstract] [Full Text] [Related]
13. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and cxcr4/RhoA pathways.
Zhao M; Wang Y; Zhang Y; Li X; Mi J; Wang Q; Geng Z; Zuo L; Song X; Ge S; Zhang Z; Tang M; Li H; Wang Z; Jiang C; Su F
BMC Gastroenterol; 2022 Aug; 22(1):378. PubMed ID: 35941537
[TBL] [Abstract] [Full Text] [Related]
14. Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms.
Skov V; Thomassen M; Kjær L; Ellervik C; Larsen MK; Knudsen TA; Kruse TA; Hasselbalch HC
PLoS One; 2022; 17(6):e0270669. PubMed ID: 35771847
[TBL] [Abstract] [Full Text] [Related]
15. Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy.
Blair AB; Wang J; Davelaar J; Baker A; Li K; Niu N; Wang J; Shao Y; Funes V; Li P; Pachter JA; Maneval DC; Dezem F; Plummer J; Chan KS; Gong J; Hendifar AE; Pandol SJ; Burkhart R; Zhang Y; Zheng L; Osipov A
Gastroenterology; 2022 Nov; 163(5):1267-1280.e7. PubMed ID: 35718227
[TBL] [Abstract] [Full Text] [Related]
16. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy.
Xiao Y; Chen J; Zhou H; Zeng X; Ruan Z; Pu Z; Jiang X; Matsui A; Zhu L; Amoozgar Z; Chen DS; Han X; Duda DG; Shi J
Nat Commun; 2022 Feb; 13(1):758. PubMed ID: 35140208
[TBL] [Abstract] [Full Text] [Related]
17. cxcr4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.
Zhao D; Yang Z; Chen C; Zhang Z; Yu Y; Li Z
FEBS Open Bio; 2021 Nov; 11(11):3115-3125. PubMed ID: 34555268
[TBL] [Abstract] [Full Text] [Related]
18. Biokinetics and Dosimetry of
Hänscheid H; Schirbel A; Hartrampf P; Kraus S; Werner RA; Einsele H; Wester HJ; Lassmann M; Kortüm M; Buck AK
J Nucl Med; 2022 May; 63(5):754-760. PubMed ID: 34413147
[TBL] [Abstract] [Full Text] [Related]
19. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and cxcr4 Inhibition for the treatment of CCl
Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D
Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436
[TBL] [Abstract] [Full Text] [Related]
20. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Correia AL; Guimaraes JC; Auf der Maur P; De Silva D; Trefny MP; Okamoto R; Bruno S; Schmidt A; Mertz K; Volkmann K; Terracciano L; Zippelius A; Vetter M; Kurzeder C; Weber WP; Bentires-Alj M
Nature; 2021 Jun; 594(7864):566-571. PubMed ID: 34079127
[TBL] [Abstract] [Full Text] [Related]
[Next]
